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Introduction {#sec1}
============

Regenerative cardiomyogenesis is influenced by molecular signals that originate from injured cardiac tissues and noncardiac cells that are recruited to the injury microenvironment ([@bib19], [@bib50]). The epicardium and endocardium, tissues that line the outside and inside of the myocardium, respectively, serve as reservoirs for proliferative mitogens such as fibroblast growth factors, platelet-derived growth factor (PDGF), and retinoic acid ([@bib20], [@bib26], [@bib33], [@bib15], [@bib22]). Activation of these factors stimulates the expansion of the myocardium during development and *de novo* synthesis of cardiomyocytes (CMs) during regeneration ([@bib25], [@bib37], [@bib31], [@bib20]). More recently, immune cells have emerged as important sculptors of the injury niche ([@bib24], [@bib10], [@bib39], [@bib27]). Through cytokine release, immune cells may influence the balance between inflammation and regenerative repair. Moreover, macrophages and regulatory T cells are necessary to stimulate both appendage and heart regeneration processes in non-amniotic vertebrates and mammals ([@bib2], [@bib13], [@bib16], [@bib38]).

The tumor necrosis factor (TNF) superfamily of proinflammatory cytokines is produced by immune and nonimmune cells, including macrophages, natural killer cells, neutrophils, mast cells, fibroblast, CMs, and endothelial cells ([@bib7], [@bib54]). The TNF cytokine signal is transduced by binding with the TNFR1 and TNFR2 receptors leading to the activation of nuclear factor kappa-light-chain-enhancer of activated B cells, Mitogen-activated protein kinases, and programmed cell death pathways ([@bib32]). There is a growing appreciation that the timing, strength, and duration of inflammatory signals after injury are key to enable pro-regenerative signals to exert effects on cell proliferation ([@bib23], [@bib12]). However, to date, our understanding of the regulatory circuits that control proinflammatory signals in highly regenerative systems are largely unknown.

MicroRNAs (miRNAs) are small, highly conserved noncoding RNAs that bind target transcripts through sequence complementarity in the 3′ UTR leading to mRNA decay and inhibition of protein translation ([@bib3]). Studies from numerous groups have demonstrated that miRNAs are both necessary and sufficient to stimulate critical cellular processes of heart regeneration, including CM proliferation and collagen tissue resolution ([@bib4], [@bib56], [@bib1], [@bib5], [@bib6], [@bib28], [@bib46], [@bib47], [@bib48], [@bib52]). Given the importance of these genetic regulators on regeneration, it remains a priority to define roles for additional miRNAs and the downstream signaling pathways, in an effort to identify novel intrinsic and extrinsic factors that control heart regeneration.

Let-7 is a highly conserved family of miRNAs that contains 10--12 members, each sharing an identical seed sequence region within the mature miRNA. Processing of both primary and precursor structures of let-7 into mature single-stranded miRNAs is inhibited by interactions with the RNA-binding protein Lin28 ([@bib34], [@bib40], [@bib53]). Although let-7 was first identified as a heterochronic gene in *C. elegans*, subsequent research has shown pervasive roles during development, including cellular differentiation, tumor progression, and onset of disease ([@bib44], [@bib8], [@bib43], [@bib30], [@bib45], [@bib35], [@bib55]). Interestingly, increases in let-7 levels during postnatal cardiac development coincide with the loss of regenerative capacity, suggesting that let-7 may function to inhibit heart muscle regeneration ([@bib41]). More recently, the Dimmeler lab demonstrated that depletion of let-7a, let-7b, and let-7c following myocardial infarction protects the adult mouse heart from adverse remodeling and loss of cardiac output ([@bib45]). However, studies aimed at addressing functional roles for let-7 in a cardiac regenerative model remain outstanding.

Here we show that let-7 downregulation of TNF signaling promotes wound closure and CM proliferation during zebrafish heart regeneration. In response to cardiac resection, let-7i is robustly upregulated in the epicardium throughout phases of active CM dedifferentiation and proliferation. Depletion of let-7 expression with locked nucleic acid (LNA) antisense oligonucleotides and inducible transgenic overexpression of *lin28* culminates in pleiotropic effects on heart regeneration, including defective wound closure, suppression of CM proliferation, and pronounced ventricular wound engorgement. Surprisingly, CM dedifferentiation was unaffected under conditions of repressed let-7 activity. Conversely, ectopic activation of let-7i enhances CM proliferation, but without augmenting the rate of wound closure. Using transcriptome profiling studies, we identified an enrichment of the TNF signaling pathway as direct and indirect target genes of let-7. Importantly, co-inhibition of let-7 and TNF rescued regeneration defects mediated by let-7 suppression alone, suggesting that dampening of TNF activity is a primary mechanism of action for let-7. In addition, preconditioning zebrafish with a pharmacological inhibitor of TNF before the onset of injury resulted in defective CM proliferation, suggesting a requirement for inflammation in early stages of heart regeneration. In summary, our studies reveal that upregulation of let-7 levels in response to acute heart injury creates a heart-regeneration-conducive microenvironment by suppression of the proinflammatory cytokine TNF.

Results {#sec2}
=======

Quantification of Let-7 Family Members during Heart Regeneration in Adult Zebrafish {#sec2.1}
-----------------------------------------------------------------------------------

In previous profiling studies, we observed that dre-let-7i was one of the several zebrafish miRNAs that was robustly upregulated in response to resection of adult ventricles, when compared with uninjured ventricles ([@bib56]). The zebrafish genome encodes 10 distinct let-7 genes, let-7a through let-7j, each sharing a highly conserved mature sequence ([Figure S1](#mmc1){ref-type="supplementary-material"}). To determine the expression profile of each let-7 family member, we first performed real-time quantitative PCR (qPCR) studies during a time course of heart regeneration using LNA primers ([Table S1](#mmc1){ref-type="supplementary-material"}). When compared with uninjured ventricles, let-7f and let-7i expression levels were significantly upregulated, whereas let-7a, let-7b, let-7c, and let-7d were downregulated at 3 days post-amputation (dpa) ([Figure 1](#fig1){ref-type="fig"}A). Of the family members that are significantly upregulated or downregulated, only let-7i showed an expression change that was maintained for all stages of heart regeneration, suggesting that it may have stimulatory and maintenance roles during heart regeneration. Let-7i expression is upregulated by ∼3.6-fold at 3 dpa and remains elevated by at least 2-fold until the completion of regeneration at 30 dpa, when expression returns to near-uninjured levels ([Figure 1](#fig1){ref-type="fig"}A).Figure 1Members of the Let-7 microRNA Family Are Upregulated in Response to Heart Resection(A) Real-time qPCR analysis reveal let-7i as the most highly upregulated family member throughout regeneration.(B--D) Representative fluorescence-activated cell sorting plots of *Tg(cmcl2:GFP)*, *Tg(tcf21:Dsred);Tg(fli1a:GFP),* and *Tg(mpeg1:YFP)* transgenic hearts from uninjured ventricles.(E and F) qPCR analysis of let-7i expression in *cmlc2*, *tcf21*, *fli1a,* and *mpeg1* sorted cells in either uninjured (E) or 3-dpa hearts (F). Let-7i is confined to *tcf21* cells in the uninjured state and enriched in *tcf21*, *fli1a,* and to a lesser extent, *mpeg1*-positive cells at 3 dpa.(G and H) Real-time qPCR studies show elevated levels of *cmlc2*, *tcf21*, *fli1a,* and *mpeg1* expression in the appropriate fluorescent cells isolated from uninjured hearts. Values are means ± SE. \*p \< 0.05 compared with uninjured ventricles (A), relative to *cmlc2*-positive cells (E and F) or fluorescence-negative cells (G and H); dpa = days post-amputation.

As heart regeneration is influenced by molecular cues from CM and noncardiomyocyte cells, we defined the tissue distribution of let-7i expression with fluorescence-activated cell sorting (FACS) experiments. Using transgenic reporter strains *Tg(cmlc2:GFP), Tg(tcf21:Dsred)*, *Tg(fli1a:GFP),* and *Tg(mpeg1:YFP)* we isolated CMs, epicardial and endocardial cells, and macrophages, respectively, from uninjured and 3-dpa ventricles ([Figures 1](#fig1){ref-type="fig"}B--1D). Subsequent real-time qPCR studies on cDNA generated from these cell populations revealed that mature let-7i expression levels are higher in the epicardium in uninjured hearts, when compared with CMs and endocardial cells ([Figure 1](#fig1){ref-type="fig"}E). At 3 dpa let-7i expression levels were robustly upregulated by ∼20-fold in the epicardium, 5-fold in the endocardium, and 1.7-fold in the macrophages ([Figure 1](#fig1){ref-type="fig"}F). Let-7f expression levels were modestly upregulated in *fli1a:GFP* and *mpeg1:YFP* sorted cells. Quantification by qPCR of *cmlc2*, *tcf21*, *fli1a,* and *mpeg1* mRNA levels in sorted 3-dpa cell populations served as internal controls for FACS ([Figures 1](#fig1){ref-type="fig"}G and 1H). Together, these studies show that let-7i levels are highly upregulated within the epicardium and to a lesser extent, increased in the endocardium during heart regeneration of adult animals.

Depletion of Let-7 Causes Defects in Epicardium Migration {#sec2.2}
---------------------------------------------------------

To define the potential role for let-7, we administered a cocktail of three antisense LNA oligonucleotides directed against the entire let-7 family of miRNAs and extracted hearts at specific stages for analyses ([Figure 2](#fig2){ref-type="fig"}A). Intraperitoneal (i.p.) microinjections of LNA-let-7 oligonucleotides resulted in a strong depletion of mature levels for each let-7 family member, as shown by qPCR studies at 3 dpa ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}A). In particular, let-7i levels were depleted by ∼95% relative to expression levels in scrambled control-treated hearts. Treatment with LNA-let-7, however, did not induce significant changes in expression levels of other miRNAs ([Figure S2](#mmc1){ref-type="supplementary-material"}B). i.p. injection of a single LNA oligonucleotide directed against only let-7i, however, resulted in promiscuous depletion of other let-7 genes, possibly due to the high degree of sequence conservation among family members ([Figure S3](#mmc1){ref-type="supplementary-material"}).Figure 2Let-7 Depletion Results in Defects in Wound Closure(A) Schematic of locked nucleic acid (LNA) microinjection paradigm to deplete let-7 expression.(B and C) (B) Real-time qPCR analyses show that LNA treatment results in significant knockdown of mature let-7 expression at 3 dpa, when compared with scrambled control LNA oligonucleotides. Values are means ± SE. \*p \< 0.05, (n = 4). (C) Representative images of *tcf21:Dsred* expression in scrambled LNA control and LNA-let-7-treated hearts at 3, 14, and 21 dpa showing defects in wound closure. Scale bar, 50 μm. Brackets indicate approximate resection plane.(D) Quantification of *tcf21:Dsred* expression levels within the resection zone. Values are means ± SE. \*p \< 0.05, (n = 8--10). i.p., intraperitoneal; dpa, days post-amputation; NS, not significant.

The epicardium is a thin outer tissue layer of the ventricle that migrates across the resected zone, akin to wound closure following appendage amputation, a critical first step in the regenerative process ([@bib49]). Given that let-7i levels are highest in the epicardium ([Figure 1](#fig1){ref-type="fig"}C), we reasoned that wound healing could be disrupted in the absence of let-7 activity. To address this possibility, we administered either scrambled or LNA-let-7 oligonucleotides into injured *Tg(tcf21:Dsred)* adult animals and assessed *tcf21* expression across the wound border. In scrambled control hearts, *tcf21* cells envelope the injury zone by 14 dpa, forming a contiguous band of epicardial cells ([Figure 2](#fig2){ref-type="fig"}C). By 21 dpa, *tcf21*-positive cells were observed within the regenerating ventricle ([Figure 2](#fig2){ref-type="fig"}C), presumably differentiating into vascular support cells. By contrast, LNA-let-7-treated hearts exhibit a strong block in wound closure. In 14- and 21-dpa hearts, *tcf21* cells fail to traverse the injury zone ([Figure 2](#fig2){ref-type="fig"}C), suggesting that let-7 is a key regulator of wound closure during heart regeneration. Quantification of *tcf21:Dsred* expression within the resection wound showed no differences at 3 dpa (4.2% versus 2.4%) but robust reduction at 14 dpa (52% versus 3.2%) and 21 dpa (68% versus 5.6%) in LNA-let-7-treated hearts when compared with scrambled controls ([Figure 2](#fig2){ref-type="fig"}D).

Let-7 Controls Injury-Induced CM Proliferation {#sec2.3}
----------------------------------------------

In addition to a role during wound closure, the epicardium is also a critical source of molecular signals that influence CM dedifferentiation and proliferation ([@bib20], [@bib25], [@bib31], [@bib37]). To address this potential role for let-7, we first quantified CM proliferation indices. Scrambled control and LNA-let-7-treated hearts were cryosectioned and stained with antibodies directed against Mef2, a CM marker, and PCNA, a marker for cell cycle activity ([Figure 3](#fig3){ref-type="fig"}A). CM proliferation indices were defined as a percentage of Mef2+ PCNA+ cells over the total number of Mef2+ cells within a defined region of the injury border zone. Depletion of let-7 activity suppressed CM proliferation indices from 7.9% to 2% at 3 dpa and from 11.0% to 6.1% at 7 dpa, a decrease of 74.7% and 45%, respectively, relative to scrambled control hearts ([Figure 3](#fig3){ref-type="fig"}B).Figure 3Let-7 Activity Is Required for Heart Regeneration(A) Representative images showing proliferating CMs in scrambled LNA control and LNA-let-7-treated fish. Arrowheads indicate Mef2+ PCNA+ cells at the injury zone (n = 10--12). Scale bars, 50 μm in top three panels and 25 μm in magnified images (bottom panel).(B) CM proliferation indices are suppressed by 72% and 48% in LNA-let-7 hearts at 3 and 7 dpa, respectively, when compared with scrambled LNA control treatment. Values are means ± SE; \*p \< 0.05.(C) Representative images of hematoxylin and eosin staining of 14 dpa control and LNA-let-7-treated hearts reveal a spectrum of heart regeneration defects, categorized as normal, mild, and severe. (N = 21). Dashed lines mark approximate resection plane; dpa = days post-amputation.(D) Representative images of Acid Fushin Orange G (AFOG) stains of control and LNA-let-7-administered hearts reveal more collagen and fibrin tissue within the injury zone (N = 10). Brackets mark the injury zone. Brown, muscle; red, fibrin; blue, collagen.

Defects in wound closure and suppression of CM proliferation indices mediated by depletion of let-7 activity resulted in a spectrum of heart regeneration phenotypes by 14 dpa. We qualitatively assigned these defects into three major categories: normal, mild, and severe, based on the degree of empty space, or lack of cellular content, within the wound and severity of the clot bulge at the resection site. Hearts that displayed normal wound closure curvature across the injury zone and contained a minimum of 75% cellular content were assigned a normal phenotype. If, however, either of these metrics was lacking, hearts were scored as a mild phenotype. Hearts that displayed abnormal curvature across the resection zone and had less than 25% cellular content within the injury zone were assigned a severe phenotype. This assessment revealed that 29% (6/21) of LNA-let-7 treated hearts were normal, 43% (9/21) exhibited mild defects, and 28% (6/21) showed the most severe defects in heart regeneration ([Figure 3](#fig3){ref-type="fig"}C). On the contrary, 95% (20/21) of scrambled control hearts showed normal regeneration.

Defective wound closure and suppressed CM proliferation in LNA-let-7-depleted hearts culminated in residual scar tissue at 21 and 30 dpa. In contrast to resolution of collagen tissue of control hearts, we noted interstitial collagen tissue within the regenerated new muscle at 21 dpa, and prominent patches of fibrin and collagen tissue within the injury zone at 30 dpa ([Figure 3](#fig3){ref-type="fig"}D).

In addition to an antisense oligonucleotide approach, we also employed inducible activation of the *lin28a* cDNA under the control of the *hsp70* promoter, *Tg(hs:lin28a),* as an alternate method to suppress let-7 activity. Lin28 is an RNA-binding protein that binds to and inhibits processing of let-7 hairpin structures into mature single-stranded molecules ([@bib34], [@bib40]). In response to ventricular resection, *lin28a* mRNA levels were suppressed by 45% at 3 dpa, and 65% at 5 dpa, relative to expression levels in uninjured hearts ([Figure S4](#mmc1){ref-type="supplementary-material"}A). This decrease in *lin28a* levels coincides with the upregulation of let-7i expression ([Figure 1](#fig1){ref-type="fig"}A). Heat activation of multiple independent insertions of *Tg(hs:lin28a)* resulted in upregulation of *lin28a* transcripts ([Figure S4](#mmc1){ref-type="supplementary-material"}B) and a strong reduction of mature let-7i, when compared with heat-treated transgenic negative clutchmates ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Importantly, Lin28a-mediated repression of let-7 activity suppressed CM proliferation indices from 9.3% to 3.4%, a repression of 63.4%, similar to levels observed by LNA-let-7 treatment ([Figures S4](#mmc1){ref-type="supplementary-material"}D, S4E, and [3](#fig3){ref-type="fig"}B).

CM Dedifferentiation Is Unaffected by Depletion of Let-7 Activity {#sec2.4}
-----------------------------------------------------------------

CM proliferation in adult zebrafish and mammals is preceded by cellular dedifferentiation of spared heart cells ([@bib18], [@bib21], [@bib42]). Depletion of let-7 expression suppressed CM proliferation, suggesting that cellular dedifferentiation may also be disrupted. Using transmission electron microscopy, we analyzed changes to CM sarcomeric structure in remote and injury border zones of scrambled and LNA-let-7-treated hearts at 7 dpa ([Figure 4](#fig4){ref-type="fig"}). In the remote zone of control hearts, sarcomeric structures were well defined with distinguishable Z-lines that flank myosin and actin filaments ([Figure 4](#fig4){ref-type="fig"}A, top panels). As anticipated, CM sarcomeres were disorganized and detached in the peri-injury zone, consistent with previous observations of cellular dedifferentiation ([Figure 4](#fig4){ref-type="fig"}A, bottom panels). Surprisingly, LNA-let-7-treated hearts showed similar changes to sarcomeric structures in remote and injury zones ([Figure 4](#fig4){ref-type="fig"}A). Depletion of let-7 did not disrupt CM dedifferentiation.Figure 4CM Dedifferentiation Is Normal under Conditions of Decreased Let-7 Activity(A) Representative transmission electron microscopic images of remote and injury zones of resected 7-dpa hearts from scrambled control and LNA-let-7-treated hearts. Brackets mark intact CM sarcomeres in a remote zone. By contrast, asterisks highlight disorganized and dedifferentiated myosin bundles at the injury zone, (n = 4). Scale bar, 500 nm.(B) Representative images showing activation of *Tg(gata4:GFP)* expression in the primordial muscle layer in scrambled control and LNA-let-7-treated hearts at 7 dpa. Brackets in upper panels show approximate resection injury plane. Arrowheads in magnified bottom panels show *gata4:GFP* expression in both scrambled LNA control and LNA-let-7-treated hearts. (n = 6).(C) Quantification of *gata4:GFP* expression levels at the injury border and remote zones show no differences between control and LNA-let-7-treated hearts. Values are means ± SE. (N = 6).

Normal CM dedifferentiation in LNA-let-7 hearts was also observed using the *Tg(gata4:GFP)* reporter strain. At 7 dpa, *Tg(gata4:GFP)* is activated in the primordial muscle cells, which undergo cellular dedifferentiation and proliferation to repopulate the wounded apex ([@bib57]). In both scrambled and LNA-let-7-treated hearts, *Tg(gata4:GFP)* expression was indistinguishable, indicating that CM dedifferentiation was not disrupted ([Figure 4](#fig4){ref-type="fig"}B). Quantification of *gata4:GFP* expression at the injury border and remote zones of control and LNA-let-7 hearts revealed no significant differences in relative levels ([Figure 4](#fig4){ref-type="fig"}C). Together, these studies show that let-7 is required for CM proliferation but dispensable for dedifferentiation.

Continued Elevation of Let-7 Activity Is Required for Heart Regeneration {#sec2.5}
------------------------------------------------------------------------

The sustained upregulation of let-7i during heart regeneration raised the possibility that it may have a role in maintaining CM proliferation. To test this model, we resected ventricles and allowed regeneration to proceed for 14 days to enable complete wound closure ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). On days 15--17, animals were treated with either scrambled or LNA-let-7 oligonucleotides, and hearts were extracted for CM proliferation analyses at 21 dpa. This delayed let-7 inhibition suppressed CM proliferation indices by 53%, from 1.8% in scrambled control hearts to 0.9% in LNA-let-7 hearts ([Figure S5](#mmc1){ref-type="supplementary-material"}C). Thus, let-7 activity is required for sustaining the proliferative activity of CMs at later stages of heart regeneration.

To complement our depletion studies, we also performed gain-of-function studies whereby we induced let-7i overexpression daily with a heat-inducible transgene driven by the *hsp70* promoter, *Tg(hs:let-7i-pre)* ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Heat treatment of two different *Tg(hs:let-7i-pre)* strains showed ∼3.3- and 2.5-fold increases in let-7i levels, relative to heat-shocked wild-type clutchmates ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Importantly, this enhanced let-7i expression was sufficient to stimulate a 1.4-fold increase in CM proliferation ([Figures S6](#mmc1){ref-type="supplementary-material"}C and S6D). This enhanced regenerative response, however, was not accompanied by faster wound closure, suggesting that let-7i may augment epicardium-derived molecular signals that control CM behavior ([Figures S6](#mmc1){ref-type="supplementary-material"}E and S6F).

Let-7 Dampens the Tumor Necrosis Factor Signaling Pathway in Response to Heart Injury {#sec2.6}
-------------------------------------------------------------------------------------

miRNAs exert effects on biology by refining both strength and duration of signaling pathway activation by directly binding to mRNA transcripts leading to mRNA decay and inhibiting translation ([@bib14]). To delineate the genetic circuits controlled by let-7 during heart regeneration, we performed RNA sequencing studies to identify differentially upregulated transcripts between scrambled and LNA-let-7-treated hearts at 7 dpa. These studies identified 292 genes that were significantly upregulated, of which 66 genes contained predicted binding sites for let-7 within the 3′ UTR ([Table S2](#mmc2){ref-type="supplementary-material"}). From this subset of 66 putative direct target transcripts, 9 have known or predicted association with the TNF signaling pathway ([Figure 5](#fig5){ref-type="fig"}A) ([@bib9], [@bib17]). Within the set of 292 upregulated genes were an additional 19 genes with known association with TNF that lack let-7 binding sites within the 3′ UTR ([Figure 5](#fig5){ref-type="fig"}A). The subset of nine putative let-7 target genes includes major facilitator superfamily domain containing 2ab (*mfsd2ab*), transcription factor jun-D (*jund*), chemokine receptor 4b (*cxcr4b*), plasminogen activator, urokinase a (*plaua*), ribonucleotide reductase regulatory subunit M2 (*rrm2*), Kruppel-like factor 6a (*klf6a*), fos-like 2 (*fosl2*), minichromosome maintenance complex component 5 (*mcm5*), and activating transcription factor 3 (*atf3*). Elevated expression of these transcripts in the absence of let-7 activity was confirmed with qPCR studies comparing scrambled and LNA-let-7-treated hearts at 7 dpa ([Figure 5](#fig5){ref-type="fig"}B; [Table S1](#mmc1){ref-type="supplementary-material"}). All nine putative direct targets contain a predicted let-7 binding within the transcript 3′ UTR ([Table S3](#mmc1){ref-type="supplementary-material"}).Figure 5RNA Sequencing Analysis Reveals Enrichment of Tumor Necrosis Factor Signaling in LNA-let-7-Treated Hearts(A) A gene network that depicts genes associated with TNFα function and were upregulated (red) and downregulated (green) in LNA-let-7 samples, compared with control treatment. Predicted direct target genes of let-7 are highlighted within the blue rectangle.(B) Nine TNFα-associated mRNAs with predicted binding sites for let-7 are significantly upregulated in the absence of let-7 expression, as confirmed by qPCR studies.(C) qPCR studies reveal the inverse expression relationship between let-7i and TNFα transcripts in the early stages following heart injury.(D) qPCR studies show the relative TNFα expression levels in *cmlc2*, *tcf21*, *fli1a,* and *mpeg1* 3-dpa sorted cells. TNFα expression is elevated in *mpeg1* cells and downregulated in *tcf21* cells.(E) Representative images of *Tg(BAC:TNFα:GFP)* and *(tcf21:dsRed)* expression in 1- and 3-dpa double transgenic hearts show *TNFα-GFP* activation in the epicardium and resection zone. (n = 4--6). Arrowheads indicate co-labelled cells, brackets mark approximate injury zone. Scale bar, 50 μm. Values are means ± SE. \*p \< 0.05 compared with control heart ventricles (B), uninjured heart ventricles (C), or CM expression levels (D).

Gain-of-function studies using the heat-inducible *Tg(hs:let-7i-pre)* transgene resulted in an increase in CM proliferation index without affecting epicardium migration ([Figure S6](#mmc1){ref-type="supplementary-material"}). This suggests that the two cellular responses may be controlled by distinct subgroups of let-7i target genes. To define the genes involved in CM proliferation, we examined the expression levels of TNF-associated genes that were upregulated in let-7-depleted hearts. Heat treatment of *Tg(hs:let-7i-pre)* significantly downregulated only *atf3*, *jund*, *rrm2,* and *mcm5* ([Figure S7](#mmc1){ref-type="supplementary-material"}). The data suggest that let-7 control of *atf3*, *jund*, *rrm3,* and *mcm5* may be critical for stimulating injury-induced CM proliferation.

TNF is a superfamily of multifunctional pro-inflammatory cytokines with important roles in various physiological and pathological processes, including cell proliferation, differentiation, apoptosis, modulation of immune responses, and inflammation, all of which have been implicated for tissue regeneration ([@bib32], [@bib54]). We first examined the activation of TNFα with qPCR studies beginning with the onset of ventricular resection. Transcript levels of TNFα reach peak levels by 6 h post-amputation (hpa), increasing by 3.6-fold, when compared with uninjured ventricles. By contrast, levels of let-7i only exhibit a 1.5-fold elevation by 6 hpa. By 48 hpa, TNFα levels are indistinguishable from uninjured ventricles. This drop in TNFα expression coincides with the upregulation of let-7i levels ([Figure 5](#fig5){ref-type="fig"}C).

To define the cellular distribution of TNFα signaling, we utilized two independent approaches. First, using FACS of the three cardiac tissues and macrophages, we defined the spatial and relative levels of TNFα in 3-dpa injured adult hearts. Relative to CMs, *TNFα* mRNA levels were unchanged in *fli1a:GFP+* cells, significantly elevated in *mpeg1:YFP+* cells, and strongly reduced levels in *tcf21:DsRed+* cell population ([Figure 5](#fig5){ref-type="fig"}D). Lower levels of TNFα expression in the epicardium, relative to CMs, coincide with the robust upregulation of let-7i, results consistent with TNFα as a direct target gene. An analysis of the TNFα 3′ UTR revealed a predicted binding site for let-7i ([Table S2](#mmc2){ref-type="supplementary-material"}).

Second, we employed a *Tg*(*BAC:TNFα:GFP*) reporter strain developed by the Bagnat laboratory ([@bib29]), to detect *TNFα* expression in 1- and 3-dpa hearts. In double Tg(BAC:*TNFα:GFP*), (*tcf21:DsRed*) hearts, we observed co-localization of *TNFa* and *tcf21* expression in patches of cells in the lateral walls of 1-dpa ventricles ([Figure 5](#fig5){ref-type="fig"}E, top panel). By 3 dpa, *TNFα:GFP* levels did not co-label with *tcf21:Dsred*-marked cells. Instead, *TNFα:GFP* expression was strongest within the resected zone ([Figure 5](#fig5){ref-type="fig"}D, bottom panel). Given that *TNFα* mRNA levels were upregulated in macrophages in our FACS experiments ([Figure 5](#fig5){ref-type="fig"}D), it suggests that *TNFα* expression may be localized to macrophages by 3 dpa ([Figure 5](#fig5){ref-type="fig"}E).

Co-suppression of Let-7 and Tumor Necrosis Factor Restores Let-7-Mediated Suppression of CM Proliferation {#sec2.7}
---------------------------------------------------------------------------------------------------------

The activation and duration of pro-inflammatory signals has been shown to be critical in creating an instructive microenvironment for tissue regeneration. Our data suggest that let-7 regulation of wound closure and CM proliferation is executed in part through its control of epicardial TNF signaling. To test this model, we performed co-inhibition studies with a pharmacological inhibitor of TNFα activity, CAY10500, and LNA-let-7 treatment. In a dose response study, we treated injured hearts with 5 and 15 μg/g CAY10500, extracted hearts at 3 dpa, and generated cDNA for qPCR analysis of TNFα-associated genes. These studies showed that 15 μg/g CAY10500 treatment was sufficient to significantly repress TNFα-associated transcripts, relative to PBS vehicle controls ([Figure S8](#mmc1){ref-type="supplementary-material"}). We treated *Tg(tcf21:Dsred)* animals with either vehicle, LNA-let-7 or LNA-let-7, with 15 μg/g CAY10500 and assessed the effects on wound closure at 14 dpa ([Figures 6](#fig6){ref-type="fig"}A--6D). These studies revealed that whereas LNA-let-7-depleted hearts were devoid of *tcf21+* cells within the injury zone, co-treatment with CAY10500 restored *tcf21* cell migration across the resected apex. Quantification of *tcf21:DsRed* expression within the resection zone revealed that the rate of complete wound closure increased from 30.2% (4/13) in LNA-let-7 treatment to 77.8% (7/9) in LNA-let-7 and CAY10500 co-treated hearts ([Figures 6](#fig6){ref-type="fig"}A--6D). Conversely, vehicle treatment showed 93% (13/14) success in wound healing ([Figure 6](#fig6){ref-type="fig"}A).Figure 6Co-suppression of Let-7 and TNF-α Activity Restores Defective Regeneration Processes Induced By Let-7 Depletion Alone(A--G) (A--C) Representative *tcf21:Dsred* expression at 14 dpa and (E--G) CM proliferation at 3 dpa, in vehicle, LNA-let-7, and LNA-let-7 with CAY10500 treatment. Brackets indicate approximate amputation planes. Arrowheads mark Mef2+ PCNA+ cells. (n = 9--14). Scale bar, 50 μm. (D) Quantification of *tcf21:Dsred* expression within the injury zone reveals migration of epicardial cells across the resected zone under conditions of CAY10500 and LNA-let-7 co-treatment. (n = 10).(H) Quantification of CM proliferation indices reveals LNA-let-7 treatment alone suppressed proliferation indices by 48%, whereas co-treatment with LNA-let-7 and CAY10500 restores CM proliferation indices to levels comparable to vehicle treatment. Values are means ± SE. \*p \< 0.05 compared with scrambled heart ventricles.

Effective rescue of epicardium migration defects raised the potential that repression in CM proliferation may also be restored to control levels when LNA-let-7 and CAY10500 were co-administered to injured hearts. Therefore we extracted hearts from vehicle, LNA-let-7, and LNA-let-7 and CAY10500 treatments at 3 dpa and defined CM proliferation indices. LNA-let-7 administration repressed CM proliferation indices to 3.8%, when compared with 7.4% in vehicle treatment. Co-treatment with LNA-let-7 and CAY10500, however, elevated proliferation indices to 7.7%, an increase of ∼51%, making it indistinguishable from vehicle treatment ([Figures 6](#fig6){ref-type="fig"}E--6H). Treatment with CAY10500 alone, interestingly, did not have a significant effect on CM proliferation, when compared with the vehicle treatment group ([Figure 6](#fig6){ref-type="fig"}H).

Given that attenuation of TNFα signaling after injury is important for heart regeneration, we questioned whether preconditioning the heart with pharmacological inhibition of TNFα before resection would enhance CM proliferation. We treated hearts for 3 days with daily i.p. injection of vehicle or CAY10500. On day 4, animals were i.p. treated in the morning and ventricles were resected 4--6 h later. Animals continued to receive either vehicle or CAY10500 for the duration of the experiment, and hearts were then extracted at 3 dpa for CM proliferation studies ([Figure 7](#fig7){ref-type="fig"}A). Depletion of TNFα activity before injury, surprisingly, resulted in a significant 52% reduction in CM proliferation indices (8.5% versus 4.4%) ([Figures 7](#fig7){ref-type="fig"}B and 7C). In addition, hematoxylin and eosin staining of 3-dpa hearts showed wound closure defects in CAY10500-pretreated hearts, as revealed by enlarged clots at the ventricular apex (6/6) ([Figure 7](#fig7){ref-type="fig"}D). This wound-induced bulge is similar to defects in epicardium migration that we observed under conditions of let-7 depletion. By contrast, control hearts showed normal (5/6) or minimal disruption in wound closure (1/6). Thus these preconditioning studies suggest that heart regeneration is highly sensitive to changes in TNFα activity at the onset of resection. Taken together, our studies show that let-7 stimulates and maintains heart regeneration in adult animals by attenuating epicardium-derived TNFα activity.Figure 7Preconditioning Hearts with CAY10500 Culminates in Pleiotropic Defects in Regeneration(A) An outline of the treatment paradigm for preconditioning animals with CAY10500.(B) Representative images of 3-dpa hearts stained with antibodies to detect Mef2 and PCNA. Arrowheads indicate Mef2+PCNA+ cells.(C) Quantification of cardiomyocyte proliferation indices was determined by calculating the percent of Mef+ PCNA+ cells over total Mef2+ cells. Preconditioning animals with CAY10500 suppressed CM proliferation by 49% (n = 12).(D) Representative hematoxylin and eosin images of 3-dpa hearts show normal wound closure in vehicle (control) and enlarged clots in CAY10500 hearts. (n = 10). Values are means ± SE. \*p \< 0.05 compared with control heart ventricles. Brackets represent approximate resection plane in (B and D).

Our studies on zebrafish heart regeneration suggest a model whereby ventricular resection triggers the upregulation of let-7i, primarily within the epicardium, and to a lesser extent in macrophages ([Figure 8](#fig8){ref-type="fig"}). This increase in let-7i levels, in turn, represses TNFα and its associated signaling factors through predicted miRNA-binding sites within the transcript 3′ UTR. The fine-tuning of TNFα activity by let-7i to a regeneration-instructive zone drives epicardium wound closure and CM proliferation ([Figure 8](#fig8){ref-type="fig"}).Figure 8A Model of Let-7/TNF-α Control of Heart RegenerationHeart resection stimulates upregulation of let-7i levels prominently in the epicardium, and to a lesser extent, in macrophages. Let-7i represses TNFα expression to a proliferation instructive level by direct binding and degrading transcripts. Optimized levels of TNFα create a regeneration-instructive microenvironment resulting in CM proliferation and epicardial cell migration during heart regeneration.

Discussion {#sec3}
==========

Heart regeneration is a complex process that requires communication among many different cells that inhabit the niche-specific injury microenvironment. Key among these signals are cytokines released from immune cells that shift the microenvironment between states of inflammation and regeneration. Studies across taxa suggest that limiting the duration and magnitude of inflammation is a cornerstone of tissue regeneration. Hence defining the regulatory control that fine-tunes inflammation remains an important goal for the cardiac regenerative community.

miRNAs are potent regulators of gene expression, capable of confining signaling pathways to a biologically relevant Goldilocks zone. In this study, we describe a new role for the let-7 miRNA as a regulator of the prototypical inflammatory cytokine, TNF. This model is supported by several key findings in our study. Upon ventricular resection and throughout heart regeneration, let-7i levels are significantly upregulated and confined primarily to the epicardium ([Figure 1](#fig1){ref-type="fig"}). Its upregulation coincides with the downregulation of TNF downstream components of the signaling cascade ([Figure 5](#fig5){ref-type="fig"}). Moreover, RNA sequencing experiments identify an enrichment of TNF-associated factors, both direct and secondary targets of let-7 when miRNA expression is suppressed ([Figure 5](#fig5){ref-type="fig"}). Using multiple strategies to deplete let-7 expression we observed pleiotropic defects on heart regeneration, including a strong defect in wound closure and suppressed CM proliferation indices, partly due to elevated levels of TNF activity ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). Surprisingly, CM dedifferentiation was unaffected ([Figure 4](#fig4){ref-type="fig"}). Importantly, co-inhibition of let-7 and TNFα activity rescues regeneration defects mediated by let-7 suppression alone ([Figure 6](#fig6){ref-type="fig"}).

Let-7 is an evolutionarily conserved miRNA family, and yet its role during heart regeneration is markedly different between zebrafish and mammals. Although differences in the direction of change in gene expression may account for some of the disparate responses to injury, an equally important factor in determining regenerative capacity is the cellular context of miRNA expression ([@bib41], [@bib45], [@bib56], [@bib52]). Numerous reports indicate that let-7 is expressed in mammalian cardiac tissues, but it is unclear if the expression is restricted to a specific cardiac tissue. By contrast, our studies show that let-7i is primarily induced in the epicardium, and to a lesser extent, the endocardium, thus suggesting that let-7 promotes new CM synthesis by altering the microenvironment ([Figure 1](#fig1){ref-type="fig"}).

Our functional studies depleted the entire family of miRNAs with a cocktail of LNA oligonucleotides or overexpression of *lin28* ([Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, and [S3](#mmc1){ref-type="supplementary-material"}). Of the 10 let-7 family members, let-7i is the most highly upregulated and its expression remains elevated throughout regeneration ([Figure 1](#fig1){ref-type="fig"}). This family member is not, however, upregulated in the mammalian heart following a myocardial infarction. Our attempts to deplete let-7i alone resulted in promiscuous knockdown of other family members ([Figure S2](#mmc1){ref-type="supplementary-material"}), thus leaving the specific requirement of let-7i alone an unanswered question. It does, nonetheless, raise an intriguing possibility that temporal overexpression of let-7i in the epicardium of adult mammalian hearts may stimulate regenerative response in an otherwise regeneration-incompetent system.

Production of proinflammatory cytokines has traditionally been a primary role of immune cells, most notably macrophages. Surprisingly, our studies in the regenerating adult zebrafish cardiac tissues reveal fine-tuning of TNFα expression in the epicardium, a tissue that has not been known to produce TNFα signaling or associated with inflammation, is a critical driver for epicardium wound closure and CM proliferation. Our data identify the epicardium as an important early source of inflammatory signals. One potential mechanism of epicardium-derived TNFα-mediated control of CM proliferation is through paracrine-like signaling cascades, akin to the documented roles of retinoic acid and PDGF during heart development and regeneration ([@bib20], [@bib11], [@bib22]). Although inflammation has long been considered a major impediment to regeneration, more recent studies comparing regeneration of medaka and zebrafish hearts demonstrate that the timing and strength of inflammation is a determinant of CM proliferation ([@bib23]). Attenuation of immune response compromises cardiac regenerative processes in the zebrafish, whereas enhancing the timing of acute inflammation in medaka stimulates regeneration.

Our results strengthen these observations from the Stainier laboratory ([@bib23]). Suppression of TNFα activity before resection culminated in an open wound and robust repression of CM proliferation, akin to defects noted in LNA-let-7-treated hearts ([Figure S6](#mmc1){ref-type="supplementary-material"}). Given that TNFα has been implicated in clotting, it is likely that incomplete envelopment by the epicardium weakens the overall integrity of the ventricle, thereby compromising the heart\'s ability to withstand the force of continuous contractions ([@bib36], [@bib51]). This could, in turn, explain the high penetrance of wound-induced cardiac bulge phenotype we observed in both TNFα precondition and in LNA-let-7-treated hearts. Together, these results show that heart regeneration is highly sensitive to levels of TNFα activity. In sum, our studies show that let-7 functions to refine both the magnitude and duration of TNF-mediated inflammation to create a cardiac-regeneration-instructive microenvironment.

Limitations of the Study {#sec3.1}
------------------------

In this study we demonstrate that upregulation of the miRNA let-7 stimulates wound closure and CM proliferation during heart regeneration by reducing proinflammatory factor TNFα activity in nonmyocyte cells. Although we localized let-7i expression primarily to the epicardium and macrophages using FACS studies, we recognize that fluorescent transgenic reporter strains driven by the endogenous let-7i locus could reveal a more dynamic modulation of miRNA activity, both in terms of magnitude of gene expression changes and tissue distribution. The extent that epicardium and macrophage-derived TNFα signals contribute to heart regeneration cellular processes, however, remains to be defined. Interestingly, our let-7 gain-of-function studies suggest that wound closure is controlled by a different subset of TNFα-related genes than those required for CM proliferation. Defining the contributions of these candidate factors will refine our understanding of the connectivity between inflammation and heart regeneration cellular processes, as well as the mechanism of miRNA fine-tuning of inflammatory signals during tissue repair and regeneration.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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Document S1. Transparent Methods, Figures S1--S8, and Tables S1 and S3Table S2. LNA-let-7 RNA Sequencing Gene List, Related to Figure 5
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